The following nonnarcotic substances which may, under the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 301 ), be lawfully sold over the counter without a prescription, are excluded from all schedules pursuant to section 201(g) (1) of the Act ( 21 U.S.C. 811(g) (1) ):
EXCLUDED NONNARCOTIC PRODUCTS
| Company |
Trade name |
NDC code |
Form |
Controlled substance |
(mg or mg/ml) |
| Aphena Pharma Solutions-New York, LLC |
Nasal Decongestant Inhaler/Vapor Inhaler |
|
IN |
Levmetamfetamine (l-Desoxyephedrine) |
50.00 |
| Bioline Laboratories |
Theophed |
00719-1945 |
TB |
Phenobarbital |
8.00 |
| Goldline Laboratories |
Guiaphed Elixir |
00182-1377 |
EL |
Phenobarbital |
4.00 |
| Goldline Laboratories |
Tedrigen Tablets |
00182-0134 |
TB |
Phenobarbital |
8.00 |
| Hawthorne Products Inc |
Choate's Leg Freeze |
|
LQ |
Chloral hydrate |
246.67 |
| Parke-Davis & Co |
Tedral |
00071-0230 |
TB |
Phenobarbital |
8.00 |
| Parke-Davis & Co |
Tedral Elixir |
00071-0242 |
EX |
Phenobarbital |
40.00 |
| Parke-Davis & Co |
Tedral S.A. |
00071-0231 |
TB |
Phenobarbital |
8.00 |
| Parke-Davis & Co |
Tedral Suspension |
00071-0237 |
SU |
Phenobarbital |
80.00 |
| Parmed Pharmacy |
Asma-Ese |
00349-2018 |
TB |
Phenobarbital |
8.10 |
| Procter & Gamble Co., The |
Vicks VapoInhaler |
37000-686-01 |
IN |
Levmetamfetamine (l-Desoxyephedrine) |
50.00 |
| Rondex Labs |
Azma-Aids |
00367-3153 |
TB |
Phenobarbital |
8.00 |
| Smith Kline Consumer |
Benzedrex |
49692-0928 |
IN |
Propylhexedrine |
250.00 |
| Sterling Drug, Inc |
Bronkolixir |
00057-1004 |
EL |
Phenobarbital |
0.80 |
| Sterling Drug, Inc |
Bronkotabs |
00057-1005 |
TB |
Phenobarbital |
8.00 |
| White Hall Labs |
Primatene (P-tablets) |
00573-2940 |
TB |
Phenobarbital |
8.00 |
38 FR 8255, 3/30/1973. Redesignated at 38 FR 26609, 9/24/1973, and amended at 41 FR 16553, 4/20/1976; 41 FR 53477, 12/7/1976; 46 FR 51603, 10/21/1981; 47 FR 45867, 10/14/1982; 54 FR 2100, 1/19/1989; 55 FR 12162, 3/30/1990; 62 FR 13968, 3/24/1997; 74 FR 44283, 8/28/2009; 80 FR 65634, 65637, 10/27/2015; 81 FR 6453, 2/8/2016